0 Comments
0 Shares
1K Views
0 Reviews
Sponsored
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Asia-Pacific Non-Small Cell Lung Cancer Diagnostics Market Surges with Rising Cancer Prevalence"Executive Summary Asia-Pacific Non-Small Cell Lung Cancer Diagnostics Market Size and Share Analysis Report CAGR Value The Asia-Pacific non-small cell lung cancer diagnostics market size was valued at USD 575.47 billion in 2025 and is expected to reach USD 1711.98 billion by 2033, at a CAGR of 14.60% during the forecast period This Asia-Pacific...0 Comments 0 Shares 1K Views 0 Reviews
-
Brigatinib API Market to Reach 89.7 Million by 2034 Driven by Rising Lung Cancer CasesAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 765 Views 0 Reviews
-
Europe Lung Cancer Screening Software Market Opportunities: Growth, Share, Value, Size, and Scope"Detailed Analysis of Executive Summary Europe Lung Cancer Screening Software Market Size and Share Data Bridge Market Research analyzes that the Europe lung cancer screening software market is expected to reach the value of USD 27,518.34 thousand by 2029, at a CAGR of 19.6% during the forecast period. Cloud based solutions accounts for largest mode of delivery segment in the market....0 Comments 0 Shares 1K Views 0 Reviews
-
Europe Non-Small Cell Lung Cancer Diagnostics Market Expands with Precision Oncology Investments"Latest Insights on Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Share and Size CAGR Value The Europe non-small cell lung cancer diagnostics market size was valued at USD 850.07 billion in 2025 and is expected to reach USD 2181.09 billion by 2033, at a CAGR of 12.50% during the forecast period The study and analysis conducted...0 Comments 0 Shares 1K Views 0 Reviews
-
Global MET Inhibitors for Lung Cancer Market to Reach USD 2.5 Billion by 2032 at 8.5% CAGRAccording to a newly published market research report by 24LifeSciences, the global MET inhibitors for lung cancer market was valued at USD 1.1 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252032. MET inhibitors represent a breakthrough class of targeted cancer therapies...0 Comments 0 Shares 874 Views 0 Reviews
-
Global MET Inhibitors for Lung Cancer Market to Reach USD 2.5 Billion by 2032 at 8.5% CAGRAccording to a newly published market research report by 24LifeSciences, the global MET inhibitors for lung cancer market was valued at USD 1.1 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252032. MET inhibitors represent a breakthrough class of targeted cancer therapies...0 Comments 0 Shares 924 Views 0 Reviews
-
Lung Cancer Screening Software Market Industry Statistics: Growth, Share, Value, Insights, and TrendsIntroduction Lung cancer remains one of the leading causes of cancer-related mortality worldwide, accounting for a significant share of global cancer deaths each year. The disease is often diagnosed at advanced stages due to the absence of early symptoms, which substantially reduces survival rates. As a result, early detection has become a critical focus area for healthcare systems,...0 Comments 0 Shares 1K Views 0 Reviews
-
Lung Cancer Screening Software Market Revenue Analysis: Growth, Share, Value, Scope, and Insights"Detailed Analysis of Executive Summary Lung Cancer Screening Software Market Size and Share The global lung cancer screening software market size was valued at USD 47.38 billion in 2024 and is expected to reach USD 195.75 billion by 2032, at a CAGR of 19.40% during the forecast period. With this Lung Cancer Screening Software Market report, businesses...0 Comments 0 Shares 1K Views 0 Reviews
-
Lung Cancer Surgery Market Gains Traction with Improved Early Diagnosis ProgramsThe Lung Cancer Surgery Market is experiencing steady growth due to the rising global burden of lung cancer, increasing awareness regarding early diagnosis, and continuous advancements in surgical technologies. Surgical intervention remains a critical treatment option for patients diagnosed with early-stage and localized lung cancer, driving demand for effective and precise surgical procedures....0 Comments 0 Shares 554 Views 0 Reviews
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 2K Views 0 Reviews
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Comments 0 Shares 2K Views 0 Reviews
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comments 0 Shares 2K Views 0 Reviews
-
Global Pembrolizumab Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global Pembrolizumab market was valued at USD 21.8 billion in 2025 and is projected to grow from USD 24.3 billion in 2026 to USD 42.7 billion by 2034, exhibiting a robust CAGR of 7.3% during the forecast period. This growth is driven by increasing cancer prevalence, rising immunotherapy adoption, expanding regulatory approvals for new...0 Comments 0 Shares 960 Views 0 Reviews
More Results
Sponsored
Sponsored
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek